Using genotype data to distinguish pleiotropy from heterogeneity: deciphering coheritability in autoimmune and neuropsychiatric diseases

Buhm Han,Jennie G Pouget,Kamil Slowikowski,Eli Stahl,Cue Hyunkyu Lee,Dorothee Diogo,Xinli Hu,Yu Rang Park,Eunji Kim,Peter K Gregersen,Solbritt Rantapää Dahlqvist,Jane Worthington,Javier Martin,Steve Eyre,Lars Klareskog,Tom Huizinga,Wei-Min Chen,Suna Onengut-Gumuscu,Stephen S Rich,Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium,Naomi Wray,Soumya Raychaudhuri
DOI: https://doi.org/10.1101/030783
2015-01-01
bioRxiv
Abstract:Shared genetic architecture between phenotypes may be driven by a common genetic basis (pleiotropy) or a subset of genetically similar individuals (heterogeneity). We developed BUHMBOX, a well-powered statistical method to distinguish pleiotropy from heterogeneity using genotype data. We observed a shared genetic basis between 11 of 17 tested autoimmune diseases and type I diabetes (T1D, p<10−12) and 11 of 17 tested autoimmune diseases and rheumatoid arthritis (RA, p<10−7). This sharing could not be explained by heterogeneity (corrected pBUHMBOX>0.2 using 6,670 T1D cases and 7,279 RA cases), suggesting that shared genetic features in autoimmunity are due to pleiotropy. We observed a shared genetic basis between seronegative and seropostive RA (p<10−22), explained by heterogeneity (pBUHMBOX=0.008 in 2,406 seronegative RA cases). Consistent with previous observations, we observed genetic sharing between major depressive disorder (MDD) and schizophrenia (p<10−9). This sharing is not explained by heterogeneity (pBUHMBOX=0.28 in 9,238 MDD cases).
What problem does this paper attempt to address?